Daniel Gaudet

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Hypertriglyceridemic Waist

Isabelle Lemieux, Agnès Pascot, Charles Couillard et al. · Circulation · 2000 · 934 citations · Full text

Medicine, Cardiology, Endocrinology +14

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

Frederick J. Raal, Raúl D. Santos, Dirk Blom et al. · The Lancet · 2010 · 906 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

Henry N. Ginsberg, Chris J. Packard, M. John Chapman et al. · European Heart Journal · 2021 · 899 citations · Full text

Life Sciences, Biochemistry, Cardiology +17

Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease

John D. Rioux, Mark J. Daly, Mark S. Silverberg et al. · Nature Genetics · 2001 · 782 citations

Life Sciences, Genetics, Molecular Genetics +16